Estadísticas
Número total de visitas
| Visualizaciones | |
|---|---|
| Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | 123 |
Visitas al mes
| enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | mayo 2024 | junio 2024 | julio 2024 | |
|---|---|---|---|---|---|---|---|
| Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost–utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study) | 4 | 2 | 1 | 4 | 8 | 4 | 9 |
Descargas del fichero
| Visualizaciones | |
|---|---|
| 79985.pdf | 90 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 77 |
| España | 9 |
| Irlanda | 8 |
| Brasil | 6 |
| Polonia | 4 |
| Argentina | 3 |
| Canadá | 2 |
| China | 2 |
| Hungría | 2 |
| Bélgica | 1 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Oakland | 16 |
| Ann Arbor | 9 |
| Menlo Park | 9 |
| Ashburn | 8 |
| Fairfield | 7 |
| Mountain View | 7 |
| Castellón | 6 |
| Dublin | 5 |
| San Diego | 5 |
| Cambridge | 3 |
